$118.78
-1.00-0.83%
At close: Dec 16, 4:00 PM EST
$118.78
N/A
After Hours: 5:41 PM EST
Gilead Sciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
The most recent guidance for Gilead Sciences (GILD) was reported on October 30, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $8.05 to $8.25, compared to the estimated EPS of $8.05. Additionally, Gilead Sciences forecasted revenue between $28.40B and $28.70B for the quarter.
Browse guidance and forecast on all stocks.